Doctors to make millions from Australian IVF clinic sale
Although IVF is said to be a US$3 billion industry in the United States, it is seldom reported in the financial press. However, the sale of one of the world’s most prominent IVF clinics, Melbourne IVF, in Australia, has brought some figures to light. Private equity firms are reportedly interested in buying the business for about A$200 million. The 20 shareholders would pocket some tidy sums, according to the Australian Financial Review. A sale would value the shares of Dr Gab Kovacs at $13.8 million, managing director Donna Howlett at $9.3 million, and biologist Alan Trounson at $8.8 million. Melbourne IVF is Australia’s largest clinic, followed by IVF Australia and Sydney IVF. The three account for more than a third of Australia’s authorised clinics.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
A first in France: a trans mum and a trans dad
Trigger warning: if you are easily confused by gender pronouns, this story from France may cause heart palpitations. February 19...
Nigerian power couple convicted in London over organ trafficking plot
In May last year, a young Nigerian man stumbled into a police station into the English town of Staines, in...
Cease and desist: Dutch sperm donor who has fathered 550 children is being sued
A Dutch woman and a foundation for children of sperm donors are suing a Dutch man for fathering too many...
Should intractable mental illness make you eligible for euthanasia?
Canada is in the middle of a vigorous debate about whether incurable mental illness is grounds for Medical Assistance in...
Belgium to permit multiple gender ID changes
Belgium will permit people to change their gender identity as often as they want. The Minister of Justice, Vincent Van...
Nature’s foray into politics may have backfired
In the 2020 election, a swag of high-profile science journals, including Nature, Science, The Lancet, and the New England Journal...